Key result
The synergistic use of cardiac imaging techniques and biomarkers will enhance the investigation and management of cardiovascular conditions including ischemic heart disease and heart failure.
Combining advanced cardiac imaging with novel biomarkers has the potential to synergistically improve the evaluation and management of multiple cardiovascular conditions.
May support combined imaging-biomarker strategies in ischemic heart disease and heart failure; leaves open prospective validation before practice change.
BACKGROUND: Sophisticated methods of cardiac imaging have the potential to revolutionize the care of patients with cardiovascular disease. The benefits of these state-of-the art imaging techniques can be enhanced by their use in combination with new cardiac biomarkers. This review addresses potentially useful interactions between imaging and biomarkers. CONTENT: Areas were defined in which the combined use of novel imaging techniques and biomarkers would be most beneficial. This review addresses multiple cardiovascular conditions for which the useful aspects of imaging and biomarkers are likely to be positively synergistic, including acute and chronic ischemic heart disease, heart failure, myocarditis, hypertension, and atherosclerosis. CONCLUSIONS: The synergistic use of imaging techniques and biomarkers will enhance the investigation of many key issues and questions and will be an important resource in the future.
No takes yet. Share an insight, caveat, or question.
Allan S. Jaffe (2008) conducted a review in Cardiovascular disease. Combined use of cardiac imaging and biomarkers was evaluated. The synergistic use of cardiac imaging techniques and biomarkers will enhance the investigation and management of cardiovascular conditions including ischemic heart disease and heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: